GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Defining the Roles of Bone Marrow Adipocytes and FABP4/5 Signaling in Multiple Myeloma Drug Resistance

$385,581
Michaela R. Reagan · Mainehealth · R37 · FY2023 · CA

Regulation of dendritic cell function and tumor immunity by TIM-3

$385,581
Brian Ruffell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen

$385,576
Hongjiao Ouyang · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA

Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches

$385,560
Keith Syson Chan · Methodist Hospital Research Institute · R01 · FY2025 · CA

Molecular Analysis of OSCC Tumor Invasion

$385,558
Bert W O'Malley · University Of Pennsylvania · R01 · FY2009 · DE

Localizing Immunotherapy to Improve Therapeutic Index

$385,527
Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2014 · CA

Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment

$385,491
Eli E Bar · Case Western Reserve University · R01 · FY2017 · CA

Deciphering the function of DNp63 and MDSCs in tumor promotion and metastasis of TNBCs

$385,475
Rumela Chakrabarti · University Of Pennsylvania · R01 · FY2019 · CA

Mechanisms of immunomodulatory and anti-tumor actions of Polysaccharide Krestin

$385,472
Mary L. Disis · University Of Washington · R01 · FY2009 · AT

Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma

$385,456
Ursula Anne Matulonis · Dana-Farber Cancer Inst · P50 · FY2021 · CA

Definition of Microenvironment in Breast Cancer

$385,454
Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · R37 · FY2013 · CA

Mitochondrial stress promotes immunosuppressive potential of myeloid subsets in tumors

$385,444
Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA

Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy

$385,444
Eduardo M Sotomayor · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA

CANCAN - Kaiser

$385,439
Bette J Caan · Kaiser Foundation Research Institute · OT2 · FY2022 · CA

An interactive analysis toolkit for single cell RNA-seq in cancer research

$385,402
William Evan Johnson · Boston University Medical Campus · U01 · FY2018 · CA

Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte

$385,225
John A. Petros · Cedars-Sinai Medical Center · P01 · FY2012 · CA

Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC

$385,204
Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC

$385,204
Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

MRI Characterization of Biological Risk of Ductal Carcinoma in Situ

$385,198
Habibollah Rahbar · University Of Washington · R01 · FY2018 · CA

MRI Characterization of Biological Risk of Ductal Carcinoma in Situ

$385,198
Habibollah Rahbar · University Of Washington · R01 · FY2020 · CA

The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis

$385,162
Mark L Day · University Of Michigan At Ann Arbor · R01 · FY2014 · CA

Cell lineage as an indicator of immune response in neuroblastoma

$385,110
Rani E George · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Targeting metastatic tumors with engineered cellular therapies

$385,097
Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2024 · CA

Core C: Biospecimen, Pathology, and Genomics Core

$385,012
David L Rimm · Yale University · P50 · FY2021 · CA

Non-perturbative imaging of intracellular drug exposure and drug response of kinase inhibitors

$385,003
Dan Fu · University Of Washington · R35 · FY2020 · GM